Signatur Biosciences

Signatur Biosciences is a biotechnology company developing a molecular diagnostic platform that encodes complex RNA gene expression signatures into single qPCR reactions.

The technology enables precision diagnostics to be performed on standard laboratory instruments already present in clinical settings, removing dependence on centralised genomic sequencing facilities.

The company's lead application is a breast cancer prognostic test to guide chemotherapy decisions, with further oncology indications in development.